Love Cats, But Suffer From Allergies? ALLERCA Inc. to Develop the World's First Hypo-Allergenic Cats as an Alternative to Current Allergy Treatments
Tuesday October 26, 8:35 am ET
LOS ANGELES, Oct. 26 /PRNewswire/ -- ALLERCA Inc. today launched a project to produce the world's first hypoallergenic cats. The hypoallergenic cats produced by ALLERCA will allow consumers to enjoy the love and companionship of a pet without the cost, inconvenience, risk, and limited effectiveness of current allergy treatments. Clients will take delivery of the first ALLERCA kittens in 2007. The hypoallergenic cat is the first of a planned series of lifestyle pets that ALLERCA will develop over the next few years.
ALLERCA's hypoallergenic cats will be a significant new alternative to the traditional treatment of cat allergies given that it eliminates the allergen at its source. Researchers will use patented biotechnology to suppress the allergen-producing gene in cats. For the first time, people who have been unable to own a cat because of their allergies will be able to have a pet of their own without the associated risks and costs of allergy treatments. The potential health benefits are also far-reaching. Treatment of cat allergies is currently a multi-billion-dollar industry, and approximately 10% of the country, or 27 million Americans, have cat allergies. Cat allergen is one of the three major risk factors for developing childhood allergies, asthma, and other respiratory diseases that are becoming a serious public health issue.
The response from animal lovers to ALLERCA's hypoallergenic cat project has been overwhelmingly positive. The company has received thousands of inquiries from the USA, Japan and Europe and already maintains a wait list. With the launch of the project, ALLERCA has implemented a web-based reservation system for those who want to be first to own and enjoy an ALLERCA hypoallergenic cat.
About ALLERCA
ALLERCA Inc. is a biotechnology company working with leading genetic technologies focusing on animal genetics, research and development. ALLERCA is currently developing the world's first hypoallergenic cat, expected in 2007. ALLERCA Inc. is headquartered in Los Angeles, California and maintains an international presence in Europe, Japan, Australia and Latin America. Read more at http://www.allerca.com.
Contact:
Simon Brodie
ALLERCA Inc.
11400 W. Olympic Blvd.
Suite 200
Los Angeles, CA 90064
Tel: 310.312.9522
Fax: 310.861.5606
Email: pr@allerca.com
Tuesday October 26, 8:35 am ET
LOS ANGELES, Oct. 26 /PRNewswire/ -- ALLERCA Inc. today launched a project to produce the world's first hypoallergenic cats. The hypoallergenic cats produced by ALLERCA will allow consumers to enjoy the love and companionship of a pet without the cost, inconvenience, risk, and limited effectiveness of current allergy treatments. Clients will take delivery of the first ALLERCA kittens in 2007. The hypoallergenic cat is the first of a planned series of lifestyle pets that ALLERCA will develop over the next few years.
ALLERCA's hypoallergenic cats will be a significant new alternative to the traditional treatment of cat allergies given that it eliminates the allergen at its source. Researchers will use patented biotechnology to suppress the allergen-producing gene in cats. For the first time, people who have been unable to own a cat because of their allergies will be able to have a pet of their own without the associated risks and costs of allergy treatments. The potential health benefits are also far-reaching. Treatment of cat allergies is currently a multi-billion-dollar industry, and approximately 10% of the country, or 27 million Americans, have cat allergies. Cat allergen is one of the three major risk factors for developing childhood allergies, asthma, and other respiratory diseases that are becoming a serious public health issue.
The response from animal lovers to ALLERCA's hypoallergenic cat project has been overwhelmingly positive. The company has received thousands of inquiries from the USA, Japan and Europe and already maintains a wait list. With the launch of the project, ALLERCA has implemented a web-based reservation system for those who want to be first to own and enjoy an ALLERCA hypoallergenic cat.
About ALLERCA
ALLERCA Inc. is a biotechnology company working with leading genetic technologies focusing on animal genetics, research and development. ALLERCA is currently developing the world's first hypoallergenic cat, expected in 2007. ALLERCA Inc. is headquartered in Los Angeles, California and maintains an international presence in Europe, Japan, Australia and Latin America. Read more at http://www.allerca.com.
Contact:
Simon Brodie
ALLERCA Inc.
11400 W. Olympic Blvd.
Suite 200
Los Angeles, CA 90064
Tel: 310.312.9522
Fax: 310.861.5606
Email: pr@allerca.com
